Skip to main content
Premium Trial:

Request an Annual Quote

Stephen Oldfield, Jan Hughes, Scott Garrett, John Wareham, Mary Tanner, David Sankaran, John Hanlon, Erkki Ruoslahti, and Masatoshi Takeichi

Premium

Stephen Oldfield has left his position of vice president of worldwide marketing for Molecular Devices, Inside Bioassays has learned. A company spokesperson declined to provide details regarding Oldfield’s departure.

Molecular Devices said it has named Jan Hughes as the new vice president of worldwide marketing. Hughes previously was vice president of product development for Molecular Devices’ high-throughput electrophysiology division.


Beckman Coulter has named Scott Garrett as its CEO, effective Feb. 21, the company said last week.

Garrett, who is currently president and chief operating officer, will replace current CEO John Wareham, who is retiring. Wareham will remain as chairman of the board until the annual shareholder meeting to be held April 7, Beckman Coulter said.

In addition, Garrett was elected to Beckman’s board of directors, effective Jan. 17, raising the number of directors to 12, the company said.

Garrett joined Beckman Coulter in 2002. He had previously served as CEO of Garrett Capital Advisors and Kendro Laboratory Products. He also has almost 20 years of experience with Baxter International/American Hospital Supply Corporation, Beckman said.


Evotec OAI said last week that Mary Tanner has been elected to the company’s supervisory board.

Tanner has 22 years of senior-level management experience in healthcare and consumer products at Lehman Brothers and Bear Stearns, Evotec said. Tanner retired from Bear Stearns in 2004, and founded Life Sciences Partners, a healthcare investment and advisory firm. Tanner obtained a degree from Harvard University in 1973 in philosophy and related fields, Evotec said.


David Sankaran has become chief financial officer and senior vice president of Accelrys, replacing John Hanlon, the San Diego-based company said last week.

Hanlon will leave Accelrys at the end of the month. Sankaran joins the company from Ocular Sciences, a contact lens manufacturer, where he was vice president and corporate controller. Prior to that, he was vice president of investor relations at PeopleSoft, and before that, vice president and corporate controller for Affymetrix. Sankaran holds an MBA from St. Mary’s College and a BSc in business from the University of Southern California.


Erkki Ruoslahti and Masatoshi Takeichi have received the 2005 Japan Prize in cell biology for elucidating molecular mechanisms of cell adhesion, the Science and Technology Foundation of Japan said.

The two researchers, who will receive the award in Tokyo on April 20, will share the ¥50 million ($490,000) prize.

Ruoslahti, a professor at the Burnham Institute in La Jolla, Calif., holds an MD, a PhD in immunology, and a BM in medicine from the University of Helsinki in Finland.

Takeichi is the director of the Riken Center for Developmental Biology in Kobe, Japan. He holds a PhD in biophysics from Kyoto University, as well as MSc and BSc degrees in biology from Nagoya University.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.